Authors: Bugaj, JE Achilefu, S Dorshow, RB Rajagopalan, R

Citation: Je. Bugaj et al., Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform, J BIOMED OP, 6(2), 2001, pp. 122-133

Authors: Bugaj, JE Erion, JL Johnson, MA Schmidt, MA Srinivasan, A

Citation: Je. Bugaj et al., Radiotherapeutic efficacy of Sm-153-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats, NUCL MED BI, 28(3), 2001, pp. 327-334

Authors: Lewis, JS Wang, M Laforest, R Wang, F Erion, JL Bugaj, JE Srinivasan, A Anderson, CJ

Citation: Js. Lewis et al., Toxicity and dosimetry of Lu-177-DOTA-Y3-octreotate in a rat model, INT J CANC, 94(6), 2001, pp. 873-877

Authors: de Jong, M Breeman, WAP Bernard, BF Bakker, WH Schaar, M van Gameren, A Bugaj, JE Erion, J Schmidt, M Srinivasan, A Krenning, EP

Citation: M. De Jong et al., [Lu-177-DOTA(0), Tyr(3)]octreotate for somatostatin receptor-targeted radionuclide therapy, INT J CANC, 92(5), 2001, pp. 628-633

Authors: Rajagopalan, R Uetrecht, P Bugaj, JE Achilefu, SA Dorshow, RB

Citation: R. Rajagopalan et al., Stabilization of the optical tracer agent indocyanine green using noncovalent interactions, PHOTOCHEM P, 71(3), 2000, pp. 347-350

Authors: Achilefu, S Dorshow, RB Bugaj, JE Rajagopalan, R

Citation: S. Achilefu et al., Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging, INV RADIOL, 35(8), 2000, pp. 479-485